In a large retrospective study, the prognostic significance of blood transf
usion (BT) and type of blood product transfused were searched in 640 curati
vely resected gastric carcinoma patients. Out of 640 patients, 222 (34.7%)
received BT and the incidence of BT was reduced from 45% in the early perio
d to 21% in the most recent period. The five-year disease-free survival was
significantly (P < 0.0001.) worse in the transfused group and BT became an
independent prognosticator (P = 0.0061) in the multivariate analysis. Pati
ents transfused with only packed red blood cells (PRBC)]had significantly (
P = 0.0258) better survival than those transfused with other types of blood
products. In conclusion, BT was found to be an independent prognosticator
in gastric carcinoma patients after curative resection. A tailored transfus
ion with PRBC, when indicated, might be the choice for better survival than
whole blood or other blood products.